- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
From
TECHNOLOGY
11:51pm
From
WORLD
6:44pm
Swiss vote for corporate pay curbs
Referendum result even broader than EU bonus caps
©Getty
From
SPECIAL REPORTS
Mar 1, 2013
China: Fears over poor air exacerbate healthcare concerns
The current crisis risks overburdening the country’s creaking medical system
- Developing nations The underworld of expat remittances
- Heady brew Brands target Africa’s emerging middle class
From
TECHNOLOGY
Feb 26, 2013
GSK flu vaccine linked to sleep disorder
Scientists find risk of narcolepsy increased
From
INDUSTRIALS
Feb 26, 2013
Croda cites niche products for sales lift
Speciality chemicals producer banks on consumer care division
Feb 25, 2013
Almirall wary over need to issue shares
Gallardo determined to maintain family’s controlling stake
From
FINANCIALS
Feb 25, 2013
Ireland ripe for M&A surge, says report
Potential deals highlighted in pharmaceutical and medical sectors
Feb 25, 2013
Royalty makes bid to take over Elan
Private equity group in move to gain access to drug income
From
LEX
Feb 25, 2013
Reckitt Benckiser: motorcycle maintenance
The pharma side is proving a creaky sidecar
Feb 25, 2013
Reckitt Benckiser hit by generic ruling
Rival versions of highly profitable Suboxone get green light
Feb 25, 2013
Genus plans further China expansion
Animal genetics group eyes joint ventures in pork farming
From
LEX
Feb 25, 2013
Elan / Royalty Pharma: gone shopping
Which investment banker-turned-pharma executive will investors back?
Feb 24, 2013
Novartis’ U-turn marks a crossroads
Retirement package for Vasella raises investor scrutiny over pay
Feb 23, 2013
Elan unveils share $1bn buyback
Drug group’s plan includes move to seek fresh acquisitions
From
MARKETS
Feb 23, 2013
Phytopharm falls after drug test failure
Trial for Parkinson’s treatment shows drug has no effects
Feb 22, 2013
Vasella admits mistakes over $78m payout
Shareholders not appeased by Novartis chairman’s concession
From
WORLD
Feb 20, 2013
Pryce faces retrial after jury discharged
Circumstances of case raise questions about jury system
From
TECHNOLOGY
Feb 20, 2013
Winners of life science prize revealed
Silicon Valley billionaires pledge $50m
Feb 19, 2013
Novartis pay criticism unlikely to abate
The group is still likely to face an uncomfortable grilling, write James Shotter and Andrew Jack
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey
*FT has grown in every major readership survey MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
-
Chief Executive Officer
Bermuda Business Development Corporation
-
European Financials Credit Analyst
Financial Services
-
Regional Leader
The Co-operative Bank
-
Commercial Development Manager
University of Liverpool
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Return of bear hug would show M&A revival
Royalty Pharma’s bid for Elan is well below a killer price